IVENIX, INC.

Profile

Company Names

IVENIX, INC.
FLUIDNET CORP

Addresses

21 WATER STREET, 4TH FLOOR, AMESBURY, MA 01913

21 WATER STREET, 4TH FLOOR, AMESBURY, MA 01913

21 WATER STREET, AMESBURY, MA 01913

1 NEW HAMPSHIRE AVE., PORTSMOUTH, NH 03801

1 NEW HAMPSHIRE AVE., SUITE 125, PORTSMOUTH, NH 03801

Phone Numbers

978-792-5000
603-570-4810

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$67,971,249.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2017-03-07 
$10,000,002.00 
$49,999,996.00 
$39,999,994.00 
Equity 
6
2015-08-21 
$14,799,997.00 
$14,799,997.00 
$0.00 
Equity 
5
2011-07-29 
$19,825,040.00 
$25,049,633.00 
$5,224,593.00 
Equity 
4
2011-02-08 
$499,999.00 
$2,000,000.00 
$1,500,001.00 
Debt 
3
2010-03-26 
$10,272,451.00 
$10,272,451.00 
$0.00 
Equity 
2
2010-02-26 
$10,272,451.00 
$10,272,451.00 
$0.00 
Equity 
1
2009-07-17 
$2,301,309.00 
$2,301,309.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JESSE 
 
AMBROSINA 
EXECUTIVE OFFICER
THOMAS 
 
BASSINGER 
DIRECTOR
BENJAMIN 
 
BULKLEY 
EXECUTIVE OFFICER, DIRECTOR
JEFFREY 
 
CARLISLE 
EXECUTIVE OFFICER, DIRECTOR
DARRELL 
 
CRATE 
DIRECTOR
DARRELL 
J. 
CRATE 
DIRECTOR
JOHN 
 
DOUGLASS 
DIRECTOR
JOHN 
M. 
DOUGLASS 
DIRECTOR
COLIN 
J. 
FOSTER 
DIRECTOR
GEORGE 
 
GRAY 
EXECUTIVE OFFICER
GEORGE 
W. 
GRAY 
EXECUTIVE OFFICER
LAWRENCE 
 
KUBA 
EXECUTIVE OFFICER
CAROLYN 
 
MALLECK 
EXECUTIVE OFFICER
BRENT 
 
NIBARGER 
EXECUTIVE OFFICER
STUART 
 
RANDLE 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
 
SOKOLOWSKI 
EXECUTIVE OFFICER
CHRISTIAN 
 
TAUBMAN 
EXECUTIVE OFFICER
WAYNE 
B. 
WEISMAN 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-02-08 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-02-26 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-26 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-02-26 
D
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2009-07-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERINK PARTNERS LLC
NONE
NONE
ROCKPORT VENTURE SECURITIES, LLC